Form 4: electroCore Director Receives Annual Stock Unit Award

electroCore, Inc. Director Julie Ann Goldstein was granted 19,011 deferred stock units, increasing her total beneficial ownership to 101,387 shares.

Summary

• Director Julie Ann Goldstein of electroCore, Inc. (ECOR) was awarded 19,011 shares of common stock in the form of Deferred Stock Units on September 2, 2025.
• The award vests in 12 equal monthly installments from the grant date.
• Full vesting will occur earlier if the Issuer's next annual stockholder meeting or a change of control happens, provided continuous service.
• Following this transaction, Ms. Goldstein's total beneficial ownership in electroCore, Inc. is 101,387 shares.
• This total includes 10,000 previously vested shares and 1,665 shares held in NeuroSpine Ventures, for which Ms. Goldstein disclaims beneficial ownership except for her pecuniary interest.

Sentiment

Score: 6

Explanation: The filing reports a routine compensation event for a director, which is generally neutral but slightly positive as it increases insider ownership and aligns interests with shareholders.

Positives

• Increased alignment of Director Julie Ann Goldstein's interests with those of shareholders through additional equity ownership.
• The award is a standard component of director compensation, indicating ongoing commitment to the company.

Risks

• The reporting person disclaims beneficial ownership of 1,665 shares held in NeuroSpine Ventures, except to the extent of her pecuniary interest, due to lack of voting or dispositive power.

Future Outlook

The deferred stock units are subject to a vesting schedule over 12 monthly installments, or earlier upon specific corporate events, contingent on the director's continuous service, indicating an expectation of ongoing board involvement.

Industry Context

The granting of deferred stock units to directors is a common practice in publicly traded companies, serving as a form of non-cash compensation that aligns the interests of board members with long-term shareholder value creation. This is a standard mechanism for director retention and incentivization across various industries.

Comparison to Industry Standards

• The use of deferred stock units as director compensation is a widely adopted practice among U.S. public companies, including those in the medical device and biotechnology sectors, such as Nevro Corp. or Inspire Medical Systems, Inc., which often utilize equity awards to incentivize and retain independent directors.
• The vesting schedule, tied to continuous service and accelerated vesting upon specific corporate events (like a change of control or the next annual meeting), is consistent with typical corporate governance structures designed to ensure director commitment and provide liquidity events.

Related Party Transactions

• The acquisition of 19,011 deferred stock units by Director Julie Ann Goldstein constitutes a related party transaction as it involves compensation from the issuer to a member of its board of directors.

Stakeholder Impact

• Shareholders: Increased alignment of director's financial interests with long-term shareholder value due to equity ownership.

Next Steps

• Vesting of the 19,011 deferred stock units over 12 equal monthly installments.
• Potential full vesting upon the earlier of the next annual stockholder meeting or a change of control.

Key Dates

Keywords

electroCore, ECOR, Form 4, Director Compensation, Stock Award, Beneficial Ownership, Insider Transaction, Deferred Stock Units